nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—Tooth disorder—Risedronate—Paget's disease of bone	0.0254	0.0266	CcSEcCtD
Amphetamine—Accidental injury—Risedronate—Paget's disease of bone	0.0186	0.0195	CcSEcCtD
Amphetamine—Dyspepsia—Tiludronate—Paget's disease of bone	0.0158	0.0165	CcSEcCtD
Amphetamine—CARTPT—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.0157	0.346	CbGpPWpGaD
Amphetamine—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.0147	0.0154	CcSEcCtD
Amphetamine—Abdominal pain—Tiludronate—Paget's disease of bone	0.0142	0.0148	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Alendronate—Paget's disease of bone	0.0134	0.014	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Etidronic acid—Paget's disease of bone	0.0133	0.014	CcSEcCtD
Amphetamine—Injury—Risedronate—Paget's disease of bone	0.013	0.0136	CcSEcCtD
Amphetamine—Asthenia—Tiludronate—Paget's disease of bone	0.0129	0.0135	CcSEcCtD
Amphetamine—Injury—Pamidronate—Paget's disease of bone	0.0123	0.0129	CcSEcCtD
Amphetamine—Diarrhoea—Tiludronate—Paget's disease of bone	0.0123	0.0128	CcSEcCtD
Amphetamine—Dizziness—Tiludronate—Paget's disease of bone	0.0119	0.0124	CcSEcCtD
Amphetamine—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.0117	0.0123	CcSEcCtD
Amphetamine—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.0114	0.012	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Alendronate—Paget's disease of bone	0.0114	0.0119	CcSEcCtD
Amphetamine—Headache—Tiludronate—Paget's disease of bone	0.0112	0.0118	CcSEcCtD
Amphetamine—Psychotic disorder—Pamidronate—Paget's disease of bone	0.0111	0.0116	CcSEcCtD
Amphetamine—Abdominal pain upper—Risedronate—Paget's disease of bone	0.0109	0.0114	CcSEcCtD
Amphetamine—Nausea—Tiludronate—Paget's disease of bone	0.0106	0.0112	CcSEcCtD
Amphetamine—Erythema multiforme—Alendronate—Paget's disease of bone	0.00973	0.0102	CcSEcCtD
Amphetamine—Angioedema—Etidronic acid—Paget's disease of bone	0.00961	0.0101	CcSEcCtD
Amphetamine—Abdominal pain upper—Zoledronate—Paget's disease of bone	0.00947	0.00992	CcSEcCtD
Amphetamine—Depression—Risedronate—Paget's disease of bone	0.00917	0.00961	CcSEcCtD
Amphetamine—Urinary tract infection—Risedronate—Paget's disease of bone	0.00894	0.00937	CcSEcCtD
Amphetamine—Infection—Etidronic acid—Paget's disease of bone	0.00853	0.00893	CcSEcCtD
Amphetamine—Urinary tract infection—Pamidronate—Paget's disease of bone	0.0085	0.00891	CcSEcCtD
Amphetamine—Angioedema—Alendronate—Paget's disease of bone	0.00819	0.00858	CcSEcCtD
Amphetamine—Weight decreased—Zoledronate—Paget's disease of bone	0.00811	0.00849	CcSEcCtD
Amphetamine—Depression—Zoledronate—Paget's disease of bone	0.00797	0.00835	CcSEcCtD
Amphetamine—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00777	0.00814	CcSEcCtD
Amphetamine—Chest pain—Alendronate—Paget's disease of bone	0.00763	0.00799	CcSEcCtD
Amphetamine—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00756	0.00792	CcSEcCtD
Amphetamine—Constipation—Etidronic acid—Paget's disease of bone	0.00734	0.00769	CcSEcCtD
Amphetamine—Infection—Alendronate—Paget's disease of bone	0.00727	0.00761	CcSEcCtD
Amphetamine—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00702	0.00735	CcSEcCtD
Amphetamine—Urticaria—Etidronic acid—Paget's disease of bone	0.00682	0.00714	CcSEcCtD
Amphetamine—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00679	0.00711	CcSEcCtD
Amphetamine—Tension—Pamidronate—Paget's disease of bone	0.00671	0.00703	CcSEcCtD
Amphetamine—Nervousness—Pamidronate—Paget's disease of bone	0.00664	0.00695	CcSEcCtD
Amphetamine—Angioedema—Risedronate—Paget's disease of bone	0.00657	0.00688	CcSEcCtD
Amphetamine—Dyspepsia—Alendronate—Paget's disease of bone	0.00644	0.00674	CcSEcCtD
Amphetamine—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00632	0.00662	CcSEcCtD
Amphetamine—Agitation—Pamidronate—Paget's disease of bone	0.00628	0.00658	CcSEcCtD
Amphetamine—Constipation—Alendronate—Paget's disease of bone	0.00625	0.00655	CcSEcCtD
Amphetamine—Angioedema—Pamidronate—Paget's disease of bone	0.00625	0.00654	CcSEcCtD
Amphetamine—Hypertension—Risedronate—Paget's disease of bone	0.00621	0.0065	CcSEcCtD
Amphetamine—Chest pain—Risedronate—Paget's disease of bone	0.00612	0.00641	CcSEcCtD
Amphetamine—Anxiety—Risedronate—Paget's disease of bone	0.0061	0.00639	CcSEcCtD
Amphetamine—CARTPT—Circadian rythm related genes—PML—Paget's disease of bone	0.0061	0.134	CbGpPWpGaD
Amphetamine—Dry mouth—Risedronate—Paget's disease of bone	0.00599	0.00627	CcSEcCtD
Amphetamine—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00598	0.00627	CcSEcCtD
Amphetamine—Convulsion—Pamidronate—Paget's disease of bone	0.00592	0.0062	CcSEcCtD
Amphetamine—Hypertension—Pamidronate—Paget's disease of bone	0.0059	0.00618	CcSEcCtD
Amphetamine—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00587	0.00615	CcSEcCtD
Amphetamine—Tremor—Zoledronate—Paget's disease of bone	0.00585	0.00613	CcSEcCtD
Amphetamine—Infection—Risedronate—Paget's disease of bone	0.00583	0.00611	CcSEcCtD
Amphetamine—Urticaria—Alendronate—Paget's disease of bone	0.00581	0.00609	CcSEcCtD
Amphetamine—Anxiety—Pamidronate—Paget's disease of bone	0.0058	0.00608	CcSEcCtD
Amphetamine—Abdominal pain—Alendronate—Paget's disease of bone	0.00578	0.00606	CcSEcCtD
Amphetamine—Body temperature increased—Alendronate—Paget's disease of bone	0.00578	0.00606	CcSEcCtD
Amphetamine—Agitation—Zoledronate—Paget's disease of bone	0.00574	0.00601	CcSEcCtD
Amphetamine—Angioedema—Zoledronate—Paget's disease of bone	0.0057	0.00598	CcSEcCtD
Amphetamine—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00558	0.00584	CcSEcCtD
Amphetamine—Infection—Pamidronate—Paget's disease of bone	0.00554	0.00581	CcSEcCtD
Amphetamine—Palpitations—Zoledronate—Paget's disease of bone	0.00552	0.00578	CcSEcCtD
Amphetamine—Vomiting—Etidronic acid—Paget's disease of bone	0.00546	0.00572	CcSEcCtD
Amphetamine—Tachycardia—Pamidronate—Paget's disease of bone	0.00544	0.0057	CcSEcCtD
Amphetamine—Rash—Etidronic acid—Paget's disease of bone	0.00541	0.00567	CcSEcCtD
Amphetamine—Convulsion—Zoledronate—Paget's disease of bone	0.00541	0.00567	CcSEcCtD
Amphetamine—Dermatitis—Etidronic acid—Paget's disease of bone	0.00541	0.00566	CcSEcCtD
Amphetamine—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00539	0.00565	CcSEcCtD
Amphetamine—Hypertension—Zoledronate—Paget's disease of bone	0.00539	0.00565	CcSEcCtD
Amphetamine—Hypersensitivity—Alendronate—Paget's disease of bone	0.00539	0.00565	CcSEcCtD
Amphetamine—Headache—Etidronic acid—Paget's disease of bone	0.00538	0.00563	CcSEcCtD
Amphetamine—Anorexia—Pamidronate—Paget's disease of bone	0.00532	0.00557	CcSEcCtD
Amphetamine—Chest pain—Zoledronate—Paget's disease of bone	0.00532	0.00557	CcSEcCtD
Amphetamine—Insomnia—Risedronate—Paget's disease of bone	0.00531	0.00556	CcSEcCtD
Amphetamine—Anxiety—Zoledronate—Paget's disease of bone	0.0053	0.00555	CcSEcCtD
Amphetamine—Asthenia—Alendronate—Paget's disease of bone	0.00525	0.0055	CcSEcCtD
Amphetamine—Dyspnoea—Risedronate—Paget's disease of bone	0.00523	0.00548	CcSEcCtD
Amphetamine—Dry mouth—Zoledronate—Paget's disease of bone	0.0052	0.00545	CcSEcCtD
Amphetamine—Dyspepsia—Risedronate—Paget's disease of bone	0.00517	0.00541	CcSEcCtD
Amphetamine—Nausea—Etidronic acid—Paget's disease of bone	0.0051	0.00534	CcSEcCtD
Amphetamine—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.0051	0.00534	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00507	0.00531	CcSEcCtD
Amphetamine—Infection—Zoledronate—Paget's disease of bone	0.00506	0.0053	CcSEcCtD
Amphetamine—Fatigue—Risedronate—Paget's disease of bone	0.00506	0.0053	CcSEcCtD
Amphetamine—Insomnia—Pamidronate—Paget's disease of bone	0.00505	0.00529	CcSEcCtD
Amphetamine—Constipation—Risedronate—Paget's disease of bone	0.00502	0.00526	CcSEcCtD
Amphetamine—Diarrhoea—Alendronate—Paget's disease of bone	0.005	0.00524	CcSEcCtD
Amphetamine—Dyspnoea—Pamidronate—Paget's disease of bone	0.00497	0.00521	CcSEcCtD
Amphetamine—Tachycardia—Zoledronate—Paget's disease of bone	0.00497	0.00521	CcSEcCtD
Amphetamine—Somnolence—Pamidronate—Paget's disease of bone	0.00496	0.0052	CcSEcCtD
Amphetamine—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00493	0.00516	CcSEcCtD
Amphetamine—Dyspepsia—Pamidronate—Paget's disease of bone	0.00491	0.00514	CcSEcCtD
Amphetamine—Anorexia—Zoledronate—Paget's disease of bone	0.00486	0.00509	CcSEcCtD
Amphetamine—Decreased appetite—Pamidronate—Paget's disease of bone	0.00485	0.00508	CcSEcCtD
Amphetamine—Dizziness—Alendronate—Paget's disease of bone	0.00484	0.00507	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00482	0.00505	CcSEcCtD
Amphetamine—Fatigue—Pamidronate—Paget's disease of bone	0.00481	0.00504	CcSEcCtD
Amphetamine—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.0048	0.00503	CcSEcCtD
Amphetamine—Constipation—Pamidronate—Paget's disease of bone	0.00477	0.005	CcSEcCtD
Amphetamine—Urticaria—Risedronate—Paget's disease of bone	0.00466	0.00488	CcSEcCtD
Amphetamine—Vomiting—Alendronate—Paget's disease of bone	0.00465	0.00487	CcSEcCtD
Amphetamine—Abdominal pain—Risedronate—Paget's disease of bone	0.00464	0.00486	CcSEcCtD
Amphetamine—Body temperature increased—Risedronate—Paget's disease of bone	0.00464	0.00486	CcSEcCtD
Amphetamine—Rash—Alendronate—Paget's disease of bone	0.00461	0.00483	CcSEcCtD
Amphetamine—Insomnia—Zoledronate—Paget's disease of bone	0.00461	0.00483	CcSEcCtD
Amphetamine—Dermatitis—Alendronate—Paget's disease of bone	0.00461	0.00483	CcSEcCtD
Amphetamine—Headache—Alendronate—Paget's disease of bone	0.00458	0.0048	CcSEcCtD
Amphetamine—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00456	0.00478	CcSEcCtD
Amphetamine—Dyspnoea—Zoledronate—Paget's disease of bone	0.00454	0.00476	CcSEcCtD
Amphetamine—Somnolence—Zoledronate—Paget's disease of bone	0.00453	0.00475	CcSEcCtD
Amphetamine—Dyspepsia—Zoledronate—Paget's disease of bone	0.00449	0.0047	CcSEcCtD
Amphetamine—Decreased appetite—Zoledronate—Paget's disease of bone	0.00443	0.00464	CcSEcCtD
Amphetamine—Body temperature increased—Pamidronate—Paget's disease of bone	0.00441	0.00462	CcSEcCtD
Amphetamine—Abdominal pain—Pamidronate—Paget's disease of bone	0.00441	0.00462	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.0044	0.00461	CcSEcCtD
Amphetamine—Fatigue—Zoledronate—Paget's disease of bone	0.00439	0.0046	CcSEcCtD
Amphetamine—Constipation—Zoledronate—Paget's disease of bone	0.00436	0.00456	CcSEcCtD
Amphetamine—Nausea—Alendronate—Paget's disease of bone	0.00434	0.00455	CcSEcCtD
Amphetamine—Hypersensitivity—Risedronate—Paget's disease of bone	0.00432	0.00453	CcSEcCtD
Amphetamine—Asthenia—Risedronate—Paget's disease of bone	0.00421	0.00441	CcSEcCtD
Amphetamine—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00417	0.00437	CcSEcCtD
Amphetamine—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00411	0.00431	CcSEcCtD
Amphetamine—Urticaria—Zoledronate—Paget's disease of bone	0.00405	0.00424	CcSEcCtD
Amphetamine—Abdominal pain—Zoledronate—Paget's disease of bone	0.00403	0.00422	CcSEcCtD
Amphetamine—Body temperature increased—Zoledronate—Paget's disease of bone	0.00403	0.00422	CcSEcCtD
Amphetamine—Diarrhoea—Risedronate—Paget's disease of bone	0.00402	0.00421	CcSEcCtD
Amphetamine—Asthenia—Pamidronate—Paget's disease of bone	0.004	0.00419	CcSEcCtD
Amphetamine—Dizziness—Risedronate—Paget's disease of bone	0.00388	0.00407	CcSEcCtD
Amphetamine—Diarrhoea—Pamidronate—Paget's disease of bone	0.00382	0.004	CcSEcCtD
Amphetamine—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00375	0.00393	CcSEcCtD
Amphetamine—Vomiting—Risedronate—Paget's disease of bone	0.00373	0.00391	CcSEcCtD
Amphetamine—Rash—Risedronate—Paget's disease of bone	0.0037	0.00388	CcSEcCtD
Amphetamine—Dermatitis—Risedronate—Paget's disease of bone	0.0037	0.00387	CcSEcCtD
Amphetamine—Dizziness—Pamidronate—Paget's disease of bone	0.00369	0.00386	CcSEcCtD
Amphetamine—Headache—Risedronate—Paget's disease of bone	0.00368	0.00385	CcSEcCtD
Amphetamine—Asthenia—Zoledronate—Paget's disease of bone	0.00366	0.00383	CcSEcCtD
Amphetamine—Vomiting—Pamidronate—Paget's disease of bone	0.00355	0.00372	CcSEcCtD
Amphetamine—Rash—Pamidronate—Paget's disease of bone	0.00352	0.00368	CcSEcCtD
Amphetamine—Dermatitis—Pamidronate—Paget's disease of bone	0.00351	0.00368	CcSEcCtD
Amphetamine—Headache—Pamidronate—Paget's disease of bone	0.00349	0.00366	CcSEcCtD
Amphetamine—Diarrhoea—Zoledronate—Paget's disease of bone	0.00349	0.00365	CcSEcCtD
Amphetamine—Nausea—Risedronate—Paget's disease of bone	0.00349	0.00365	CcSEcCtD
Amphetamine—Dizziness—Zoledronate—Paget's disease of bone	0.00337	0.00353	CcSEcCtD
Amphetamine—Nausea—Pamidronate—Paget's disease of bone	0.00331	0.00347	CcSEcCtD
Amphetamine—Vomiting—Zoledronate—Paget's disease of bone	0.00324	0.00339	CcSEcCtD
Amphetamine—Rash—Zoledronate—Paget's disease of bone	0.00321	0.00337	CcSEcCtD
Amphetamine—Dermatitis—Zoledronate—Paget's disease of bone	0.00321	0.00336	CcSEcCtD
Amphetamine—Headache—Zoledronate—Paget's disease of bone	0.00319	0.00334	CcSEcCtD
Amphetamine—Nausea—Zoledronate—Paget's disease of bone	0.00303	0.00317	CcSEcCtD
Amphetamine—SLC6A4—Monoamine Transport—TNFRSF11B—Paget's disease of bone	0.00299	0.0658	CbGpPWpGaD
Amphetamine—SLC6A2—Monoamine Transport—TNFRSF11B—Paget's disease of bone	0.00257	0.0566	CbGpPWpGaD
Amphetamine—SLC6A3—Monoamine Transport—TNFRSF11B—Paget's disease of bone	0.00228	0.0501	CbGpPWpGaD
Amphetamine—TAAR1—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00199	0.0437	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.00158	0.0347	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.000967	0.0213	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CALCA—Paget's disease of bone	0.000722	0.0159	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000722	0.0159	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000685	0.0151	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000624	0.0137	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000622	0.0137	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—PML—Paget's disease of bone	0.000613	0.0135	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000589	0.0129	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000522	0.0115	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000486	0.0107	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000436	0.00958	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00043	0.00946	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000408	0.00897	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—VCP—Paget's disease of bone	0.000386	0.00848	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PML—Paget's disease of bone	0.000375	0.00825	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CALCA—Paget's disease of bone	0.00037	0.00814	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000367	0.00806	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000317	0.00697	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000316	0.00695	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000247	0.00542	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000225	0.00495	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CALCA—Paget's disease of bone	0.000219	0.00481	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000219	0.00481	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NUP205—Paget's disease of bone	0.000176	0.00386	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CALCA—Paget's disease of bone	0.000168	0.0037	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—INPP5D—Paget's disease of bone	0.00015	0.00329	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NUP205—Paget's disease of bone	0.000149	0.00327	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—INPP5D—Paget's disease of bone	0.000127	0.00278	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CALCA—Paget's disease of bone	9.51e-05	0.00209	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VCP—Paget's disease of bone	8.99e-05	0.00198	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALCA—Paget's disease of bone	8.64e-05	0.0019	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NUP205—Paget's disease of bone	8.55e-05	0.00188	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—INPP5D—Paget's disease of bone	7.29e-05	0.0016	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SQSTM1—Paget's disease of bone	5.25e-05	0.00116	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCA—Paget's disease of bone	5.1e-05	0.00112	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NUP205—Paget's disease of bone	4.79e-05	0.00105	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	4.09e-05	0.000899	CbGpPWpGaD
